| 000 | 01649 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250518051216.0 | ||
| 264 | 0 | _c20200103 | |
| 008 | 202001s 0 0 eng d | ||
| 022 | _a1502-7732 | ||
| 024 | 7 |
_a10.1080/03009742.2019.1600717 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBehrens, F | |
| 245 | 0 | 0 |
_aAddition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis. _h[electronic resource] |
| 260 |
_bScandinavian journal of rheumatology _cSep 2019 |
||
| 300 |
_a375-382 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Observational Study | ||
| 650 | 0 | 4 |
_aAdalimumab _xtherapeutic use |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aArthritis, Psoriatic _xdrug therapy |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKoehm, M | |
| 700 | 1 | _aSchwaneck, E C | |
| 700 | 1 | _aSchmalzing, M | |
| 700 | 1 | _aWittig, B M | |
| 700 | 1 | _aGnann, H | |
| 700 | 1 | _aGreger, G | |
| 700 | 1 | _aTony, H-P | |
| 700 | 1 | _aBurkhardt, H | |
| 773 | 0 |
_tScandinavian journal of rheumatology _gvol. 48 _gno. 5 _gp. 375-382 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/03009742.2019.1600717 _zAvailable from publisher's website |
| 999 |
_c29906887 _d29906887 |
||